Načítá se...
Cholesterol Efflux Capacity, Macrophage Reverse Cholesterol Transport, and Cardioprotective HDL
PURPOSE OF REVIEW: Randomized clinical trials provide strong evidence that pharmacological elevation of HDL-cholesterol (HDL-C) fails to reduce cardiovascular disease risk in statin-treated humans. It is thus critical to identify new metrics that capture HDL's cardioprotective effects. RECENT F...
Uloženo v:
| Vydáno v: | Curr Opin Lipidol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4617325/ https://ncbi.nlm.nih.gov/pubmed/26270810 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOL.0000000000000209 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|